evaluate the pharmaceuticals company wegovy on glp-1 drugs for diabetes Novo's becomes first drug approved MASH Wegovy Pill: What to Know

Reddys (DRRD) has built a strong pipeline of GLP-1 generics, including Ozempic and Rybelsus

Patients should contact their GP if they experience concerning symptoms and report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)

For users this could segway into an expansion of the private market and for payers this could provide an affordable entry point for public reimbursement

The second was a single-blind study that examined exenatide vs no additional treatment for 12 months in 45 participants, finding that at the 14-month follow-up, there was low-certainty evidence that suggests exenatide improves motor impairment as assessed by the MDS-UPDRS Part III off medication (mean difference, 4.50